BlackRock Science and Technology Term Trust (BSTZ)
NYSE NYSE Primary NASDAQ Summary
BSTZ Chart
BSTZ: How To Buy Anthropic With A Discount
BlackRock Science and Technology Term Trust offers pre-IPO exposure to high-profile tech firms like Anthropic. BSTZ focuses on total return and income, targeting long-term capital appreciation in U.S. and non-U.S. science and technology equities. As a closed-end fund, BSTZ trades at a discount or premium to NAV (currently a discount), thus creating potential for additional returns if the discount narrows.
The venture fund paying 8% yield while quietly liquidating in five years
The BlackRock Science and Technology Term Trust (NYSE:BSTZ) is an unusual tech vehicle: a closed-end fund with a 2031 liquidation date, an expense ratio near 1.4%, and over 30% of its portfolio invested in private, pre-IPO companies.
This 7.8% Dividend Is A Top Contrarian Play On The Software Crash
The time has come to make a move on this software-stock selloff. And we're going to use our favorite income plays—closed-end funds (CEFs)—to do it.
BlackRock Science and Technology Term Trust Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 19,273 | $427,947.94 | $557,567.89 | $129,619.95 | 30.29% |
 Daniel L. Lippincott Karpus Management Inc. | 409,931 | $8.24M | $11.86M | $3.62M | 43.94% |
 Kyle P. Smith NewEdge Wealth LLC | 13,066 | $255,397.2 | $376,431.46 | $121,034.26 | 47.39% |
| SE Sima Elimelech Activest Wealth Management | 6,198 | $140,136.78 | $180,299.82 | $40,163.04 | 28.66% |
 Matthew Liebman Amplius Wealth Advisors LLC | 14,525 | $283,630.29 | $400,454.25 | $116,823.96 | 41.19% |
BlackRock Science and Technology Term Trust (BSTZ) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has BlackRock Science and Technology Term Trust ever had a stock split?
BlackRock Science and Technology Term Trust Profile
| NYSE Exchange | US Country |
Overview
BlackRock Science and Technology Term Trust is a distinguished closed-ended equity mutual fund orchestrated by the prominent BlackRock, Inc. It stands operated by BlackRock Advisors, LLC, showcasing its strategic management prowess. The essence of this fund is to marshal investments into the vigorous domain of public equity markets globally. It uniquely zeroes in on the electrifying sectors of science and technology, earmarking stocks of companies that lead and innovate in these pivotal areas. By laying a keen focus on growth stocks spanning across varied market capitalizations, it offers a nuanced portfolio that aims at fostering growth. Launched in the recent past, June 2019, the fund has established its domicile in the United States, marking its presence in the competitive landscape of investment funds dedicated to the ever-evolving science and technology sectors.
Products and Services
- Global Public Equity Investments:
- Science and Technology Sector Focus:
- Growth Stock Investments:
This flagship offering sees the trust investing in the public equity markets around the world. It stands as a testament to the fund's commitment to harnessing the potential of global markets, aiming to diversify investments and mitigate region-specific risks. This approach not only broadens the investment horizon but also taps into the growth dynamism of emerging and established markets alike.
The fund places a magnified lens on companies operating within the vibrant science and technology sectors. This strategic investment thesis is built on the belief that these sectors are the epicenters of innovation and growth. Targeting companies that are leading the charge in scientific advancements and technological breakthroughs, the fund endeavors to capitalize on the rapid development and the ever-increasing importance of these industries in the global economy.
Emphasizing on growth stocks, the fund aims to partake in the potential exponential growth of companies irrespective of their market capitalizations. This segment underlines the fund’s investment in firms that exhibit signs of above-average growth compared to their industry counterparts, which could be a result of innovations, product launches, or entering new markets. Such an investment philosophy is poised to cater to investors who are looking for growth opportunities and are willing to tolerate the associated risks.
